First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 781 000 KRW Market Closed
Updated: May 15, 2024
Samsung Biologics Co Ltd
/
Income Statement
/
Income from Continuing Operations

Samsung Biologics Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Samsung Biologics Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
P
087010
K
278650
S
237690
F
220100
L
141080

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Income from Continuing Operations
₩857.7B
CAGR 3-Years
53%
CAGR 5-Years
31%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Income from Continuing Operations
-₩15.9B
CAGR 3-Years
5%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Income from Continuing Operations
-₩54.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Income from Continuing Operations
₩17.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Income from Continuing Operations
-₩6.7B
CAGR 3-Years
34%
CAGR 5-Years
11%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Income from Continuing Operations
-₩73.7B
CAGR 3-Years
-119%
CAGR 5-Years
-23%
CAGR 10-Years
-29%

See Also

What is Samsung Biologics Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
857.7B KRW

Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Income from Continuing Operations amounts to 857.7B KRW.

What is Samsung Biologics Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
31%

Over the last year, the Income from Continuing Operations growth was 7%. The average annual Income from Continuing Operations growth rates for Samsung Biologics Co Ltd have been 53% over the past three years , 31% over the past five years .

ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.